INTREPId (INTermediate Risk Erection PreservatIon Trial): A randomized trial of radiation therapy and darolutamide for prostate cancer

被引：0
|
作者：
King, Martin T.
Wise, David R.
Scala, Lawrence M.
Mariados, Neil M.
Whitbeck, Amanda
Pomerantz, Mark
Bober, Sharon
Davicioni, Elai
Bubley, Glenn
Nguyen, Paul L.
机构：
[1] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
[2] NYU, Med Ctr, New York, NY 10016 USA
[3] Kaiser Permanente, Santa Clara, CA USA
[4] Associated Med Profess New York PLLC, Syracuse, NY USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA
[7] GenomeDx Biosci Inc, Vancouver, BC, Canada
[8] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[9] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS384
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Radiation and Androgen Deprivation Therapy With or Without Docetaxel in the Management of Nonmetastatic Unfavorable-Risk Prostate Cancer: A Prospective Randomized Trial
    D'Amico, Anthony, V
    Xie, Wanling
    McMahon, Elizabeth
    Loffredo, Marian
    Medeiros, Shana
    Joseph, David
    Denham, Jim
    Kumar, Parvesh
    Bubley, Glenn
    Sullivan, Molly
    Hellwig, Richard
    Vera, Juan Carlos
    Freter, Rolf
    Baker, W. Jeffrey
    Wong, Jeffrey Y.
    Renshaw, Andrew A.
    Kantoff, Philip W.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (26) : 2938 - +
  • [32] Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial
    Hannan, Raquibul
    Tumati, Vasu
    Xie, Xian-Jin
    Cho, L. Chinsoo
    Kavanagh, Brian D.
    Brindle, Jeffrey
    Raben, David
    Nanda, Akash
    Cooley, Susan
    Kim, D. W. Nathan
    Pistenmaa, David
    Lotan, Yair
    Timmerman, Robert
    EUROPEAN JOURNAL OF CANCER, 2016, 59 : 142 - 151
  • [33] Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
    Catton, Charles N.
    Lukka, Himu
    Gu, Chu-Shu
    Martin, Jarad M.
    Supiot, Stephane
    Chung, Peter W. M.
    Bauman, Glenn S.
    Bahary, Jean-Paul
    Ahmed, Shahida
    Cheung, Patrick
    Tai, Keen Hun
    Wu, Jackson S.
    Parliament, Matthew B.
    Tsakiridis, Theodoros
    Corbett, Tom B.
    Tang, Colin
    Dayes, Ian S.
    Warde, Padraig
    Craig, Tim K.
    Julian, Jim A.
    Levine, Mark N.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (17) : 1884 - +
  • [34] Radiation therapy and irreversible electroporation for intermediate risk prostate cancer (RTIRE).
    McClure, Timothy D.
    Ballman, Karla V.
    Marciscano, Ariel E. E.
    Barbieri, Christopher
    Nagar, Himanshu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [35] Radiation therapy and IRreversible electroporation for intermediate risk prostate cancer (RTIRE)
    Diven, Marshall
    Ballman, Karla
    Marciscano, Ariel
    Barbieri, Christopher
    Piscopo, Jennifer
    Wang, Shu
    Nagar, Himanshu
    Mcclure, Timothy
    BMC UROLOGY, 2024, 24 (01):
  • [36] Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy
    Jeffrey Vainshtein
    Eyad Abu-Isa
    Karin B Olson
    Michael E Ray
    Howard M Sandler
    Dan Normolle
    Dale W Litzenberg
    Kathryn Masi
    Charlie Pan
    Daniel A Hamstra
    Radiation Oncology, 7
  • [37] Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy
    Vainshtein, Jeffrey
    Abu-Isa, Eyad
    Olson, Karin B.
    Ray, Michael E.
    Sandler, Howard M.
    Normolle, Dan
    Litzenberg, Dale W.
    Masi, Kathryn
    Pan, Charlie
    Hamstra, Daniel A.
    RADIATION ONCOLOGY, 2012, 7
  • [38] Radiation Therapy and Irreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE)
    Diven, M.
    McClure, T. D.
    Ballman, K.
    Marciscano, A. E.
    Barbieri, C. E.
    Nagar, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E377 - E378
  • [39] Duration of androgen deprivation therapy in high-risk prostate cancer: A randomized trial.
    Nabid, Abdenour
    Carrier, Nathalie
    Martin, Andre-Guy
    Bahary, Jean-Paul
    Souhami, Luis
    Duclos, Marie
    Vincent, Francois
    Vass, Sylvie
    Bahoric, Boris
    Archambault, Robert
    Lemaire, Celine
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Duration of androgen deprivation therapy in high-risk prostate cancer: A randomized trial.
    Nabid, Abdenour
    Carrier, Nathalie
    Martin, Andre-Guy
    Bahary, Jean-Paul
    Souhami, Luis
    Duclos, Marie
    Vincent, Francois
    Vass, Sylvie
    Bahoric, Boris
    Archambault, Robert
    Lemaire, Celine
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (18)
12345